SCAI joined the RRC in comments on the proposed rule governing electronic prior authorization for drugs. The comments strongly align with our previous comments regarding prior authorization in the Medicare Advantage program regarding authorization timelines and transparency.
Concerned About This and Other Issues?
Learn More About SCAI's Latest Work on Your Behalf
Article
Joint Statement of Vascular and Interventional Medical Societies on the HHS Office of Inspector General Report OEI-01-24-00250
Utilization Trends and Medicare Part B Billing for Office-Based Peripheral Vascular Procedures Raise Questions About Program Integr...